Cargando…

ACT-07 Clinical Trials of 11C-Methionine PET for brain tumors

Background: Although 11C-Methionine (MET) PET has widely used, 11C-MET tracer has not been approved in Japan. We conducted multi-center prospective clinical trials using MET for drug approval in diagnosis of brain tumors[Methods] Two trials using 11C-MET PET were performed in Hokkaido University, Os...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaguchi, Shigeru, Shiga, Tohru, Hirata, Kenji, Terasaka, Shunsuke, Kobayashi, Hiroyuki, Shimosegawa, Eku, Kagawa, Naoya, Hirayama, Ryuichi, Kinoshita, Manabu, Kijima, Haruhiko, Fujii, Masazumi, Ichikawa, Masahiro, Oriuchi, Noboru, Kuge, Yuji, Tamaki, Nagara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699097/ http://dx.doi.org/10.1093/noajnl/vdaa143.035

Ejemplares similares

Determination of brain tumor recurrence using (11)C‐methionine positron emission tomography after radiotherapy
por: Yamaguchi, Shigeru, et al.
Publicado: (2021)

Preoperative Texture Analysis Using (11)C-Methionine Positron Emission Tomography Predicts Survival after Surgery for Glioma
por: Manabe, Osamu, et al.
Publicado: (2021)

NI-07 VALIDATION OF MACHINE LEARNING BASED HIGH GRADE GLIOMA MR SEGMENTATION VIA METHIONINE PET
por: Kinoshita, Manabu, et al.
Publicado: (2019)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

IMT-07 CLINICAL TRIAL OF A COCKTAIL WILMS’ TUMOR 1 (WT1) VACCINATION USING TWO HLA CLASS I PEPTIDES AND ONE CLASS II PEPTIDE FOR RECURRENT MALIGNANT GLIOMAS
por: Kagawa, Naoki, et al.
Publicado: (2019)

STMO-10 SURGICAL RESECTION FOR PRIMARY MOTOR CORTEX GLIOMA, TWO CASE REPORTS
por: Kijima, Noriyuki, et al.
Publicado: (2019)

I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury
por: Abiko, Kagari, et al.
Publicado: (2017)

Validation of magnetic resonance imaging-based automatic high-grade glioma segmentation accuracy via (11)C-methionine positron emission tomography
por: Ozaki, Tomohiko, et al.
Publicado: (2019)

STMO-03 Surgical resection for precentral gyrus glioma
por: Kijima, Noriyuki, et al.
Publicado: (2020)

Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016)

Voxel based comparison and texture analysis of (18)F-FDG and (18)F-FMISO PET of patients with head-and-neck cancer
por: Kroenke, Markus, et al.
Publicado: (2019)

Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy
por: Oriuchi, Noboru, et al.
Publicado: (2020)

Surgical resection of glioblastoma in basal ganglia and utility of exoscope: Technical case reports
por: Kijima, Noriyuki, et al.
Publicado: (2023)

Assessment of early changes in (3)H-fluorothymidine uptake after treatment with gefitinib in human tumor xenograft in comparison with Ki-67 and phospho-EGFR expression
por: Zhao, Songji, et al.
Publicado: (2013)

ANGI-03 Functional roles of CD166/activated leukocyte cell adhesion molecule (CD166/ALCAM) for glioblastoma invasion
por: Kijima, Noriyuki, et al.
Publicado: (2020)

How Much Tumor Volume Is Responsible for Development of Clinical Symptoms in Patients With Convexity, Parasagittal, and Falx Meningiomas?
por: Yamada, Shuhei, et al.
Publicado: (2021)

Clinical Perspectives of Theranostics
por: Okamoto, Shozo, et al.
Publicado: (2021)

Quantitative pulmonary blood flow measurement using (15)O-H(2)O PET with and without tissue fraction correction: a comparison study
por: Matsunaga, Keiko, et al.
Publicado: (2017)

MNG-08 VOLUMETRIC STUDIES IN ASYMPTOMATIC MENINGIOMAS: SLOWDOWN CASES AND GROWTH ARREST CASES
por: Hirayama, Ryuichi, et al.
Publicado: (2019)

COT-18 Prognosis and problems about secondary intracranial neoplasm in childhood cancer survivors: a single-institution retrospective cohort study
por: Kagawa, Naoki, et al.
Publicado: (2020)

Influence of region-of-interest designs on quantitative measurement of multimodal imaging of MR non-enhancing gliomas
por: Takano, Koji, et al.
Publicado: (2018)

Usefulness of FMISO—PET for Glioma Analysis
por: Kobayashi, Hiroyuki, et al.
Publicado: (2013)

NI-14 estimation of property of MRI non-contrast enhanced lesion of Glioblastoma using T1/T2 ratio
por: Yamamoto, Shota, et al.
Publicado: (2021)

Prediction and Visualization of Non-Enhancing Tumor in Glioblastoma via T1w/T2w-Ratio Map
por: Yamamoto, Shota, et al.
Publicado: (2022)

Molecular imaging in heart failure patients
por: Tamaki, Nagara, et al.
Publicado: (2013)

Improvement of cerebral hypometabolism after resection of radiation-induced necrotic lesion in a patient with cerebral arteriovenous malformation
por: Harada, Yae, et al.
Publicado: (2015)

GCT-69. VOLUMETRIC CHANGE BEFORE CHEMORADIOTHERAPY AND INFLUENCE OF DIAGNOSTIC RADIATION EXPOSURE IN INTRACRANIAL GERMINOMAS
por: Kagawa, Naoki, et al.
Publicado: (2020)

TB-9 An attempt to establish a patient-derived brain tumor culture model by organoid culture method
por: Kuroda, Hideki, et al.
Publicado: (2021)

Magnetic Resonance Relaxometry for Tumor Cell Density Imaging for Glioma: An Exploratory Study via (11)C-Methionine PET and Its Validation via Stereotactic Tissue Sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

NI-3 Magnetic resonance relaxometry for tumor cell density imaging for glioma: An exploratory study via 11C-methionine PET and its validation via stereotactic tissue sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [(18)F]DiFA and comparison with [(18)F]FMISO
por: Watanabe, Shiro, et al.
Publicado: (2019)

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
por: Watanabe, Shiro, et al.
Publicado: (2019)

Optimization of [(11)C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV
por: Isohashi, Kayako, et al.
Publicado: (2013)

Elimination of tumor hypoxia by eribulin demonstrated by (18)F-FMISO hypoxia imaging in human tumor xenograft models
por: Zhao, Songji, et al.
Publicado: (2019)

QOL-44. ASSESSMENT OF NEUROCOGNITIVE FUNCTION AND MRI PARAMETERS IN LONG-TERM SURVIVORS WITH POSTERIOR FOSSA TUMORS: A COMPARISON BETWEEN MEDULLOBLASTOMAS TREATED BY REDUCED-DOSE CRANIOSPINAL IRRADIATION AND OTHER TUMORS
por: Kagawa, Naoki, et al.
Publicado: (2020)

Cerebellopontine angle metastasis of a neuroendocrine tumor mimicking vestibular schwannoma: A case report
por: Yamada, Shuhei, et al.
Publicado: (2022)

Quantitative FDG PET Assessment for Oncology Therapy
por: Hirata, Kenji, et al.
Publicado: (2021)

Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors
por: Nishikawa, Yukiko, et al.
Publicado: (2017)

COT-16 Development of automatic lesion extraction application using artificial intelligence for the purpose of simplifying tumor volume measurement of meningioma
por: Hirayama, Ryuichi, et al.
Publicado: (2021)

GCT-21. Long-term outcome and follow up of intracranial germ cell tumors: Reduced-dose radiotherapy and intensified chemotherapy improves clinical outcome and quality of life for long-term survivors
por: Kagawa, Naoki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pfi9cueogvcm6k3ge1f4em3lcf